site:markets.businessinsider.com

Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with ...

United States of AmericaDL-Notes 2022(32) Ser.F-2032 Bond

The United States of America-Bond has a maturity date of 11/15/2032 and offers a coupon of 4.1250%. The payment of the coupon will take place 2,0 times per biannual on the 15.05.. At the current price ...

POET Technologies Provides Purchase Order Update

POET Technologies Inc. ("POET" or the "Company") (NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, ...

Chicago’s Water Tower Place Announces Major Redevelopment to Modernize Iconic Mag Mile Destination

Water Tower Place, the seminal shopping destination on Chicago’s Magnificent Mile, today shared redevelopment plans for the popular and historic shopping center. Announced as the center celebrates its ...

The Southern Co.DL-Notes 2020(20/30) Bond

More Bonds of The Southern Co. Moody’s Daily Credit Risk Score About the The Southern Co.-Bond (US842587DE49) The The Southern Co.-Bond has a maturity date of 4/30/2030 and offers a coupon of 3.7000%.

Senegal, RepublikEO-Bonds 2018(26-28) Reg.S Bond

The Senegal, Republik-Bond has a maturity date of 3/13/2028 and offers a coupon of 4.7500%. The payment of the coupon will take place 1,0 times per Year on the 13.03.. At the current price of 69.9 EUR ...

Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone ...

Acquisition Positions Amneal to Capitalize on $300B+ Global Biologics LOE Opportunity –– Transaction Accelerates Growth Profile and ...

Here's how much the US government has made on its Intel investment after the latest big stock rally

The government, which took a nearly 10% stake in Intel last August, has seen gains on paper of $27 billion following the big ...

Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026

World’s first Phase 3 readout for an in vivo CRISPR gene editing candidateCompany to host webcast to discuss data at 8:00 a.m. ET on April 27, ...

Business Insider